Acute Lymphoblastic Leukemia, Pediatric Clinical Trials

15 recruiting

Frequently Asked Questions

Common questions about Acute Lymphoblastic Leukemia, Pediatric clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 115 of 15 trials

Recruiting
Not Applicable

Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3

Acute Lymphoblastic Leukemia, Pediatric
Roswell Park Cancer Institute100 enrolled1 locationNCT06074666
Recruiting
Phase 1

A Phase I Dose Finding Study of MB-CART2219.1

LymphomaCLLAcute Lymphoblastic Leukemia, Pediatric
University Hospital Tuebingen36 enrolled2 locationsNCT07108868
Recruiting
Phase 2

Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea

Acute Lymphoblastic Leukemia, Pediatric
Hyoung Jin Kang74 enrolled6 locationsNCT06257394
Recruiting
Not Applicable

Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia

Acute LeukemiaMyeloproliferative NeoplasmAcute Lymphoblastic Leukemia, Pediatric+1 more
Case Comprehensive Cancer Center20 enrolled1 locationNCT06421155
Recruiting
Phase 3

Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017

Acute Lymphoblastic Leukemia, Pediatric
Martin Schrappe5,000 enrolled115 locationsNCT03643276
Recruiting
Not Applicable

Massage Impact on Sleep in Pediatric Oncology

CancerAcute Myeloid LeukemiaChemotherapy Effect+3 more
Children's Hospital of Philadelphia70 enrolled2 locationsNCT06892158
Recruiting
Not Applicable

CD-19 CAR-T Cell for Pediatric ALL or Lymphoma

Lymphoma, B-CellAcute Lymphoblastic Leukemia, Pediatric
Hong Kong Children's Hospital18 enrolled1 locationNCT06866873
Recruiting
Phase 2

A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL

Acute Lymphoblastic Leukemia, Pediatric
The First Affiliated Hospital of Zhengzhou University276 enrolled1 locationNCT06559345
Recruiting
Phase 2

A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL

Acute Lymphoblastic Leukemia, Pediatric
The First Affiliated Hospital of Zhengzhou University170 enrolled1 locationNCT06564493
Recruiting
Phase 1

Palbociclib in Combination With Chemotherapy in Pediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (RELPALL2)

Refractory Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia, PediatricRelapsed Acute Lymphoblastic Leukemia
Tanja Andrea Gruber22 enrolled1 locationNCT04996160
Recruiting
Not Applicable

Virtual Reality During Lumbar Punctures in Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia, Pediatric
Children's National Research Institute40 enrolled1 locationNCT06722638
Recruiting
Phase 1Phase 2

Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR

Diffuse Large B Cell LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+3 more
University Hospital Heidelberg68 enrolled2 locationsNCT03676504
Recruiting
Phase 3

Combined Immuno-chemotherapy for Patients With B-linear Acute Lymphoblastic Leukemia Diagnosed From 0 to 365 Days of Life (ALL-Baby-2021)

Acute Lymphoblastic Leukemia, PediatricALL, Infants
Federal Research Institute of Pediatric Hematology, Oncology and Immunology80 enrolled1 locationNCT05029531
Recruiting

Determining the Mechanisms of Loss of CAR T Cell Persistence

Acute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia, PediatricAcute Lymphoblastic Leukemia, Adult+2 more
University College, London50 enrolled3 locationsNCT05809284
Recruiting

Long Non-coding RNAs and Their Role on Epigenome as Diagnostic Markers in Childhood Acute Lymphoblastic Leukemia of T Cells.

Acute Lymphoblastic Leukemia, Pediatric
IRCCS SYNLAB SDN20 enrolled1 locationNCT06334835